• Mashup Score: 4

    For some men with prostate cancer, a genetic biomarker test called Decipher may help predict whether the cancer will spread to other parts of the body. The test could help determine whether hormone therapy, which can cause distressing side effects, is needed.

    Tweet Tweets with this article
    • In 2021, a large study confirmed that a genetic test may correctly predict how likely it is for recurrent #ProstateCancer to spread to other parts of the body. https://t.co/k315pDjUqu #MensHealthMonth #repost

  • Mashup Score: 12

    People with neurofibromatosis type 1 (NF1) develop more types of cancer than previously recognized, according to a new study. They also developed some cancers at an earlier age and were more likely to die from several cancer types, compared with the general population. The findings emphasize the importance of preventive measures and early diagnosis for people with NF1.

    Tweet Tweets with this article
    • An inherited condition called neurofibromatosis type 1 (#NF1) is linked to the development of more types of cancer than previously realized. https://t.co/jdWzWJdUsE #repost #NFAwarenessDay

  • Mashup Score: 3

    Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a new study shows that more parents are now citing concerns about the vaccines’ safety. The findings highlight an urgent need for doctors and public health leaders to address these concerns with parents, study researchers said.

    Tweet Tweets with this article
    • Despite 15 years of consistent evidence that #HPVvaccines are safe and effective, a study has found that parents increasingly cite concerns about the vaccines' safety. https://t.co/a9LcfxVnoq #repost #HPVPreventionWeek https://t.co/saCNSWPeLG

  • Mashup Score: 1

    NCI scientists and their international collaborators have found that the majority of lung cancers in never smokers arise when mutations caused by natural processes in the body accumulate. They also identified three subtypes of lung cancer in these individuals. These insights may lead to more precise treatments.

    Tweet Tweets with this article
    • An NCI-led research team has illuminated the origins of #LungCancer among people with no history of smoking, who comprise 10-20% of all lung cancer patients. https://t.co/cjkXbcs7YO #CancerResearch #HealthNews #repost https://t.co/YXVkEhBTSR

  • Mashup Score: 8

    Women with early-stage breast cancer who had one or both breasts surgically removed (a unilateral or bilateral mastectomy) had lower scores on a quality-of-life survey than women who had breast-conserving surgery, a new study has found. The survey questions include those about psychosocial and sexual well-being.

    Tweet Tweets with this article
    • “Surgical choices that women with breast cancer make can impact their long-term quality of life,” said surgeon Dr. Laura Dominici of @DanaFarber. Researchers glean new insights for those with #BreastCancer: https://t.co/AVxDX4uDhb #BCSM #repost @FaulknerHosp https://t.co/IFeGJR0EnM

  • Mashup Score: 1

    A blood test combined with imaging tests detected tumors—some at an early stage—in women without a history of cancer or any symptoms, a recent study showed. The liquid biopsy, called CancerSEEK, also mistakenly indicated some women had cancer when additional testing determined they did not.

    Tweet Tweets with this article
    • Read about how a blood test combined with imaging tests can detect tumors—some at an early stage—in women without a history of cancer or any symptoms. Find out more. https://t.co/khl61mKs7G #CancerResearch #CancerScreening #repost https://t.co/MJ9RTVZYLT

  • Mashup Score: 6

    Nearly 750,000 cases of cancer diagnosed worldwide in 2020, or 4%, can be attributed to alcohol consumption, according to a new World Health Organization (WHO) study. While heavy drinking accounted for the most cases, light and moderate drinking accounted for more than 100,000 of those cases.

    Tweet Tweets with this article
    • Alcohol Tied to 750,000 Cancer Cases Worldwide in 2020 https://t.co/HdIXq5EUaD #NCICancerCurrentsblog #repost https://t.co/fmkHb2lArX

  • Mashup Score: 8

    A drug called 177Lu-PSMA-617 may be a new option for treating advanced prostate cancer. In a large clinical trial called VISION, participants who received 177Lu-PSMA-617—a type of drug called a radiopharmaceutical—along with standard treatments lived longer than those who received only standard therapies.

    Tweet Tweets with this article
    • For Advanced Prostate Cancer, Radiopharmaceutical Improves Survival https://t.co/YztF34Dtl1 #NCICancerCurrentsblog #repost https://t.co/T95bVbsyHP